More than 390 patients with advanced womb cancer could benefit from a new treatment option.

Durvalumab can be used with chemotherapy and then continued to help keep advanced or recurrent womb cancer under control.

Learn more: https://www.nice.org.uk/guidance/ta1190?utm_medium=organic&utm_source=x&utm_campaign=durvalumab_080926&utm_content=video